Document:

<Page>

                                                                    EXHIBIT 10.8

                        ADMINISTRATIVE SERVICES AGREEMENT

     THIS ADMINISTRATIVE SERVICES AGREEMENT (this "Agreement") made as of the
1ST day of August, 2003 (the "Effective Date") by and between BIOCHEMICS, INC.,
a corporation organized under the laws of the State of Delaware, United States
of America ("BioChemics"), and VASO ACTIVE PHARMACEUTICALS, INC., a corporation
organized under the laws of the State of Delaware, United States of America
("VAP", together with BioChemics, the "Parties" and each individually a
"Party").

     WHEREAS BioChemics owns a 100 percent interest in VAP but otherwise deals
with VAP with respect to all matters on an arm's length basis;

     AND WHEREAS the administrative resources that BioChemics uses in its
business are similar to those that are required by VAP for its business and
BioChemics is willing to provide such administrative resources to VAP in
accordance with the terms and conditions of this Agreement;

     AND WHEREAS the Parties wish to establish the principles which shall
henceforth govern the provision by BioChemics to VAP of the services referred to
herein at a fair market value for the duration of the term of this Agreement.

     NOW, THEREFORE, THIS AGREEMENT WITNESSETH THAT, in consideration of the
mutual covenants contained herein, it is agreed by and between the Parties as
follows:

                                    ARTICLE I
                                 INTERPRETATION

1.1  Definitions. For the purposes of this Agreement or any notice, consent,
request, authorization, permission, direction or other communication required or
permitted to be given hereunder, the following words and phrases shall have the
following meanings, respectively, unless the context otherwise requires:

     (a) "Administrative Services" shall have the meaning ascribed thereto at
Subsection 2.2.

     (b) "Indemnified Party" shall have the meaning ascribed thereto at
Section 6.1.

     (c) "Indemnifying Party" shall have the meaning ascribed thereto at
Section 6.1.

     (d) "Person" means any individual, sole proprietorship, trust, estate,
executor, legal representative, unincorporated association, association,
institution, corporation, company, partnership, limited liability company,
limited liability partnership, joint venture, government (whether national,
Federal, state, county, city, municipal or otherwise, including, without
limitation, any instrumentality division, agency, body or department thereof) or
other entity.

     (e) "subsidiary" of a Person means any other Person directly, or indirectly
through one or more intermediaries, controlling, controlled by or under common
control with the first Person. As used in this definition of the term
"subsidiary", and elsewhere herein with respect to any affiliate of any Person,
"control" (including the terms "controlled by" and "under common control with")
means the possession, directly or indirectly, of the power to direct or cause
the direction of the management policies of a Person, whether through the
ownership of voting securities, by voting trust, contract or similar
arrangement, as trustee or executor, or otherwise.

     (f) "Services Fee" shall have the meaning ascribed thereto at Section 4.1.

1.2  Gender. Any reference in this Agreement to any gender shall include both
genders and the neuter and words used herein imparting the singular number only
shall include the plural and vice-versa.

1.3  Headings. The division of this Agreement into Articles, Sections,
Subsections and other subdivisions and the insertion of headings are for
convenience of reference only and shall not affect or be utilized in the
construction or interpretation hereof.

                                   ARTICLE II
                             ADMINISTRATIVE SERVICES

2.1  Administrative Services. During the term of this Agreement, BioChemics,
whether directly or indirectly, shall provide to VAP, either through BioChemics
personnel or through qualified personnel hired by BioChemics, all Administrative
Services

<Page>

reasonably required or requested by VAP which are of a type normally used by
BioChemics in respect of its own business and in a manner and at a level of
service consistent with the same services utilized by BioChemics, in order to
support, advise and assist in the operations and business affairs of VAP as they
may evolve from time to time over the term of this Agreement.

2.2  Description of Administrative Services. Upon and subject to the terms of
Section 2.1, BioChemics shall provide to VAP, at VAP's reasonable request,
administrative support services including, but not limited to (i) secretarial
support services, (ii) accounting and tax services; (iii) data processing
services; (iv) the provision of utilities; (v) the provision and maintenance of
designated office space; (vi) the provision of designated warehouse and storage
space; (vii) the provision of office supplies; (viii) telephone and computer
services and equipment; and (ix) such other office and corporate support
services as may be reasonably required by VAP from time to time (each an
"Administrative Service" and collectively, the "Administrative Services").

                                   ARTICLE III
                              PROVISION OF SERVICES

3.1  Representations, Warranties and Covenants of BioChemics. BioChemics
represents, warrants and covenants to and in favor of VAP that it shall use the
same degree of care and skill in the provision of the Administrative Services to
VAP as BioChemics uses in providing similar services to itself. Except as
aforesaid, BioChemics makes no other representation, warranty or covenant,
express or implied, statutory or otherwise, as to the quality, scope or
availability of any of the Administrative Services.

                                   ARTICLE IV
                                      FEES

4.1  Services Fee. As consideration for BioChemics performing and providing the
Administrative Services in accordance with this Agreement, VAP shall pay to
BioChemics a fee equal to BioChemics' fully loaded costs (i.e. including
incidental costs) of the Administrative Services provided by BioChemics during a
given period, plus a 10% administration fee (the "Services Fee"). Where
applicable, the fee associated with a particular Administrative Service shall be
calculated on a pro-rated basis, based on the actual portion of such service
used by VAP during a given period. The Services Fee shall be paid in full within
thirty (30) days of receipt of an invoice from BioChemics. Both Parties agree
and acknowledge that the Monthly Fee is a fair and reasonable fee for the
provision of the Administrative Services by BioChemics under this Agreement.

                                    ARTICLE V
                              TERM AND TERMINATION

5.1  Term. This Agreement shall become effective on the Effective Date and,
except as otherwise provided herein, shall be in effect for an initial term of
five (5) years (the "Initial Term") and shall be automatically renewed on each
anniversary date hereof for an additional period of twelve (12) months so long
as this Agreement has not been terminated as permitted herein.

5.2. Termination by BioChemics. BioChemics may terminate this Agreement for a
material breach by VAP (including, but not limited to non-payment of Monthly
Fees) by giving VAP written notice specifying the breach relied on and giving
VAP three (3) months to cure such breach. If the default has not been cured at
the end of such three (3) month cure period, then, upon written notice thereof
to VAP by BioChemics, this Agreement shall terminate. Termination for breach
will have no effect on performance obligations or amounts to be paid which have
accrued up to the effective date of such termination.

5.3  Termination by VAP. VAP may terminate this Agreement at any time by
providing thirty (30) days written notice of such termination to BioChemics.

[5.4 Notwithstanding any other provision of this Agreement, in the event
BioChemics ceases to own beneficially, directly or indirectly, such number of
the issued and outstanding shares of the capital stock of VAP to which are
attached at least forty-nine percent (49%) of the votes that may be cast to
elect directors of VAP, then either VAP or BioChemics may terminate the
respective rights and obligations of VAP and BioChemics under this Agreement by
providing no less than forty-five (45) days prior written notice to the other,
as the case may be.]

5.5  Notwithstanding any other provision of this Agreement, in the event that
VAP shall have disposed of all or substantially all of its assets, then either
VAP or BioChemics may immediately terminate the respective rights and
obligations of VAP and BioChemics under this Agreement by providing to the other
written notice to that effect.

5.6  Obligations Upon Termination. As soon as reasonably practicable following
the date of the termination of this Agreement for any reason, BioChemics shall:

<Page>

     (a) Segregate and deliver to VAP all books and records, or copies thereof,
pertaining exclusively to VAP used in the course of, or generated by, the
provision of the Administrative Services and, after a reasonable period of time
sufficient to remove information which does not pertain to the business of VAP,
all books and records, or copies thereof, pertaining to VAP used in the course
of, or generated by, the provision of the Administrative Services; and

     (b) For a period of ninety (90) days after the termination of this
Agreement, provide to and at the option of VAP such Administrative Services as
may be reasonably requested by VAP in order to help ensure the continuity of the
business of VAP. BioChemics shall be entitled to the payment of fees for any
transitional services rendered under this Section 5.6. Such fees shall be
calculated and payable in the same manner as the Monthly Fees.

                                   ARTICLE VI
                                    REMEDIES

6.1  Indemnification. Each Party (the "Indemnifying Party") shall indemnify and
save harmless the other Party and their directors, officers and employees
(individually, an "Indemnified Party") from and against any claims, demands,
actions, causes of action, judgments, damages (excluding indirect or
consequential damages), losses (which shall include any diminution in value),
liabilities, costs or expenses (including, without limitation, interest,
penalties and reasonable attorneys' and experts' fees and disbursements) which
may be made against any Indemnified Party or which any Indemnified Party may
suffer or incur as a result of, arising out of, or relating to, any breach of
this Agreement by the Indemnifying Party.

6.2  Survival of Indemnification. Each Party's obligations of indemnification
under this Agreement shall survive the termination of this Agreement or any
termination of any Party's respective rights and obligations under Article II
hereof.

6.3  Default Interest. If any Party fails to pay as and when due and payable any
amount hereunder (including, without limitation, the Monthly Fees), then such
Party shall pay interest to the other Party on such amount from the due date up
to and including the date when such amount and all interest thereon are paid in
full at the rate of two percent (2%) per annum.

6.4  Waiver of Consequential Damages. Each Party hereby waives any right to
recover consequential, punitive, exemplary or similar damages in any
arbitration, lawsuit, litigation or proceeding arising out or resulting from
this Agreement. Each Party certifies and acknowledges that (a) no
representative, agent or attorney of any other Party has represented, expressly
or otherwise, that such other Party would not, in the event of arbitration,
litigation or other proceeding, seek to enforce the foregoing waiver, (b) it
understands and has considered the implications of this waiver, (c) it makes
this waiver voluntarily, and (d) it has been induced to enter into this
Agreement by, among other things, the mutual waivers and certifications in this
Section 6.4.

                                   ARTICLE VII
                                  MISCELLAENOUS

7.1  Utilization of Others. For the avoidance of doubt the Parties hereby
expressly agree that in providing the Administrative Services hereunder
BioChemics may utilize the advice and assistance of such other firms or persons,
including its subsidiary or affiliated companies, as it may reasonably determine
necessary or appropriate and the costs and expenses of such services shall,
without duplication, be recoverable from VAP in accordance with the provisions
of this Agreement. It is further agreed that VAP is not required to obtain any
of the Administrative Services or any other or similar services exclusively from
BioChemics and may utilize the advice and assistance of such other firms or
persons, including any subsidiaries or affiliated companies, as it may
reasonably determine necessary or appropriate in order to operate its business.

7.2  Research and Development. For the avoidance of doubt, the Parties
acknowledge and agree that the Administrative Services contemplated hereunder do
not, and shall not be construed so as to, include any transfer, license or grant
of rights from BioChemics to VAP in respect of any intellectual property rights
(including, without limitation, all domestic and foreign patents, trademarks,
copyrights, trade secrets, inventions and know-how) owned, used, developed,
leased or licensed by BioChemics or any research and development undertaken by
BioChemics (together "Intellectual Property Rights"), PROVIDED ALWAYS that any
such Intellectual Property Rights transferred to VAP from BioChemics pursuant to
any other agreement shall remain in full force and effect and shall not be
affected in any manner by the operation of this Agreement.

7.3  Assignment by BioChemics. Except as provided in this Section 7.3, this
Agreement may not be assigned by BioChemics in whole or in part. Notwithstanding
the foregoing, at any time during the term hereof, BioChemics may assign this
Agreement, upon prior written notice to VAP, to any Person that is and at all
times remains a subsidiary of BioChemics, or that merges or consolidates with or
into BioChemics or any of its subsidiaries, or that acquires all or
substantially all of the assets of BioChemics or of any of its subsidiaries.
BioChemics shall cause any Person that merges or consolidates with or into
BioChemics or any of its subsidiaries (in the event BioChemics is not the
surviving corporation in any such merger or consolidation), or that acquires all
or substantially all of the assets of BioChemics, to assume all liabilities and
obligation of BioChemics under this Agreement pursuant to

<Page>

an instrument in form and substance reasonably satisfactory to VAP. Any
purported assignment or transfer of this Agreement in violation of this Section
7.3 shall be void and of no force or effect.

7.4  Assignment by VAP. Except as provided in this Section 7.4, this Agreement
may not be assigned by VAP in whole or in part. Notwithstanding the foregoing,
at any time during the Term, VAP may assign this Agreement (a) to any lender or
lenders as security for obligations to such lender or lenders in respect of
financing arrangements of VAP or any affiliate thereof with such lender or
lenders, or (b) upon prior written notice to BioChemics, to any Person that is
and at all times remains a subsidiary of VAP controlled by VAP, or that merges
or consolidates with or into VAP, or that acquires all or substantially all of
the assets of VAP. VAP shall cause any Person that merges or consolidates with
or into VAP (in the event VAP is not the surviving corporation in any such
merger or consolidation), or that acquires all or substantially all of the
assets of VAP, to assume all liabilities and obligation of VAP under this
Agreement pursuant to an instrument in form and substance reasonably
satisfactory to BioChemics. Any purported assignment or transfer of this
Agreement in violation of this Section 7.4 shall be void and of no force or
effect.

7.5  Notices. All notices, requests, demands and other communications hereunder
shall be in writing or by electronic means producing a written record (facsimile
machine, telex, telecopier or telegraph), personally-delivered or sent by
nationally-recognized overnight courier service, effective upon delivery, or two
(2) days after sending if by overnight courier, addressed as follows:

     If to VAP:

              Vaso Active Pharmaceuticals, Inc.
              99 Rosewood Drive, Suite 260
              Danvers, MA 01923
              Attn.:  John J. Masiz, President
              Telephone Number: 978.750.0090
              Facsimile Number:  978.750.0085

     with a copy to:

              Robinson & Cole LLP
              One Boston Place
              Boston, MA 02108
              Attn.:  David A. Garbus, Esq.
              Telephone Number: (617) 557-5955
              Facsimile Number:  (617) 557-5999

     If to BioChemics:

              BioChemics, Inc.
              99 Rosewood Drive, Suite 260
              Danvers, MA 01923
              Attn.:  John J. Masiz, President
              Telephone Number: 978.750.0090
              Facsimile Number:  978.750.0085

Either Party may change its address or the addressee specified for notices by
designating a new address or addressee by notice in accordance with this Section
7.5.

7.6  Amendment; Waiver. No amendment, modification or discharge of this
Agreement, and no waiver hereunder, shall be valid or binding unless set forth
in writing and duly executed by the Party against whom enforcement of the
amendment, modification, discharge or waiver is sought. Any such waiver shall
constitute a waiver only with respect to the specific matter described in such
writing and shall in no way impair the rights of the party granting such waiver
in any other respect or at any other time. The failure of either Party to insist
in any one or more instances upon strict performance of any of the provisions of
this Agreement or take advantage of any of its rights hereunder shall not be
construed as a waiver of any such provisions or the relinquishment of any such
rights, but the same shall continue and remain in full force and effect.

7.7  Entire Agreement. This instrument constitutes the entire agreement between
the Parties relating to the subject matter hereof and there are no agreements,
understandings, conditions, representations or warranties not expressly set
forth herein.

7.8  Governing Law. All questions concerning the construction, validity, and
interpretation of this Agreement and the performance of the obligations imposed
by this Agreement shall be governed by the internal law, but not the law of
conflicts, of the State of Delaware, United States of America.

<Page>

7.9  Severability. Any term or provision of this Agreement that is invalid or
unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective
to the extent of such invalidity or unenforceability, without rendering invalid
or unenforceable the remaining terms and provisions of this Agreement or
affecting the validity or unenforceability of any of the terms or provisions of
this Agreement in any other jurisdiction. If any term or provision of this
Agreement is so broad as to be invalid or unenforceable, the provision shall be
interpreted to be only as broad as is valid or enforceable. Subject to the
foregoing provisions of this Section 7.9, if any term or provision of this
Agreement is invalid or unenforceable for any reason, such circumstances shall
not have the effect of rendering such term or provision invalid or unenforceable
in any other case or circumstance.

7.10 Counterparts. This Agreement may be signed by the Parties executed in one
or more counterparts as may be deemed necessary, each of which so signed shall
be deemed to be an original, and all such counterparts together shall constitute
one and the same instrument. Delivery of an executed signature page to this
Agreement by facsimile transmission shall be as effective as delivery of a
manually signed counterpart of this Agreement.

                      [THE NEXT PAGE IS THE SIGNATURE PAGE]

<Page>

IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and at
the place first above-mentioned.

For:              VASO ACTIVE PHARMACEUTICALS, INC.

Name:    John J. Masiz
Title:   President

Signature:  /s/ John J. Masiz
            -----------------

Date:    8/26/2004

For:      BIOCHEMICS, INC.

Name:  John J. Masiz
Title: President

Signature: /s/ John J. Masiz
           -----------------

Date:    8/26/2004QuickLinks
 -- Click here to rapidly navigate through this document

EXHIBIT 10.2 (b)  

 
 

SECOND AMENDMENT TO
  LOAN AND SECURITY AGREEMENT    
    

        THIS SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this "Amendment") is entered into as of and effective as of March 24, 2004, (the "Effective Date"),
by and among BANK OF AMERICA, NATIONAL ASSOCIATION, as administrative agent ("Administrative Agent") for the other lenders identified on the signature pages hereof (the "Lenders"), and METALS
USA, INC. and each of its subsidiaries (the "Subsidiaries") which are parties hereto (collectively, the "Borrowers"). 

 
 

RECITALS    
    

        A.    Borrowers
(meaning, in this case, all entities comprising Borrowers as of October 31, 2002), Administrative Agent and the Lenders are parties to that certain Loan
and Security Agreement dated as of October 31, 2002 (as amended, the "Agreement"; terms defined in the Agreement and not otherwise defined herein shall be used herein as defined in the
Agreement). 

        B.    Subsequent
to October 31, 2002, certain name changes and reorganizations have occurred among certain of the entities which comprised Borrowers, being generally
described as follows: 

        1.     Allmet
Building Products, L.P. changed its name to "Metals USA Building Products, L.P." 

        2.     The
following entities no longer exist due to their merger with and into Metals USA Building Products, L.P. (being the surviving entity in each such merger): 

	 	 	Cornerstone Building Products, Inc.

Cornerstone Metals Corporation

Cornerstone Patio Concepts, L.L.C.

Metals USA Building Products Southeast, Inc.

National Manufacturing, Inc.

Texas Aluminum Industries, Inc.

Valley Aluminum Co.

Valley Aluminum of Nevada, Inc.

Western Awning Company, Inc.

        C.    Borrowers,
Administrative Agent, and the Lenders desire to amend the Agreement to provide for certain modifications as set forth herein, all subject to the terms and
conditions contained herein. 

        NOW, THEREFORE, in consideration of the covenants, conditions and agreements hereafter set forth, and for other good and valuable consideration, the receipt and
adequacy of which are all hereby acknowledged, the parties hereto covenant and agree as follows: 

        1.     AMENDMENT TO THE AGREEMENT.    Effective as of the Effective Date, the Agreement is hereby amended as follows: 

        1.1   Amendment to Section 1.1 of the Agreement.    The existing definitions of the following defined terms in
Section 1.1 of the Agreement are amended and restated in their entirety to read as follows: 

        "Borrowing
Base" means, at any time, an amount equal to the lesser of 

        (a)   the
Maximum Revolver Amount, or 

        (b)   the
sum of 

          (i)  eighty-five
percent (85%) of the Net Amount of Eligible Accounts, 

plus

 

         (ii)  the
lesser of the following, but in any event not to exceed one hundred seventy five percent (175%) of the Net Amount of Eligible Accounts: 

        (A)  sixty
percent (60%) of the lesser of the original cost or market value of Eligible Inventory, or 

        (B)  the
sum of 

        (1)   ninety
percent (90%) of the Orderly Liquidation Value of the Borrowers' flat rolled Inventory, 

        plus

        (2)   eighty-five
percent (85%) of the Orderly Liquidation Value of all other Inventory of the Borrowers (i.e., exclusive of the Borrowers' flat rolled Inventory), 

minus

        (iii)  all
reserves which the Agent deems necessary in the exercise of its reasonable credit judgment to maintain with respect to any Borrower, including, without limitation,
reserves for any amounts which the Agent or any Lender may be obligated to pay in the future for the account of any Borrower. 

        Notwithstanding
the foregoing clause (b)(iii), as long as (i) Availability exceeds $20,000,000 and (ii) mark to market adjustments or reserves to
re-value Inventory on a replacement cost basis versus book value would not cause Availability against the Borrowers' Inventory (regardless of whether such Inventory is flat rolled or
otherwise) to exceed ninety percent (90%) of the Orderly Liquidation Value, as computed on the most recent Inventory appraisal, the Agent will not take reserves against Inventory as a result of such
re-valuation adjustment. 

        Any
determination by the Agent in respect of the Borrowing Base shall be based on the Agent's reasonable credit judgment. 

        "Maximum
Revolver Amount" means $250,000,000. 

        2.     Agreements
Regarding First Extension of Stated Maturity Date. Notwithstanding the terms and provisions of Section 12.1 of the Agreement, Borrowers and Lenders
agree as follows: 

        (a)   The
first automatic one-year extension of the term of this Agreement is hereby activated and is in effect as of the date of this Amendment. As a result
thereof, (i) the Agreement (subject to prior termination by Lenders or by Borrowers in accordance with Section 12.1 of the Agreement) is extended to October 31, 2006, and
(ii) there is only one automatic one-year extension remaining under Section 12.1 of the Agreement, that being the one-year extension which would have an Extension
Determination Date of October 31, 2006 in order to effect an extension of the Agreement to October 31, 2007. 

        (b)   The
renewal fee provided for in Section 3.6 of the Agreement for the first one-year extension that is presently effective pursuant to
paragraph (a) above of this Section 2 is due and payable in full as of the Effective Date. For avoidance of doubt, such renewal fee is $625,000 and is for the ratable benefit of all
Lenders based upon the dollar amount set forth beside each respective Lender's name under the heading "Commitment" on the signature pages of this Amendment. 

        (c)   By
executing this Amendment (and in lieu of the certificate to be delivered to the Administrative Agent under Section 12.1 of the Agreement), Borrowers hereby
agree that, giving effect to this Amendment and the one-year extension provided for in paragraph (a) above of this Section 2, no Default or Event of Default exists, and all
representations and warranties contained in the Agreement (subject to the last sentence of this Section 2(c)) are true and correct (and in the case of the representations contained in
Section 8.24 of the Agreement, such representation is deemed to 

2

 

relate
to the most recent available audited Financial Statements as of the date of this Amendment). The Borrowers have advised the Agent that Metals USA Flat Rolled Central, Inc.
("M-FRCI") currently is not in good standing in its jurisdiction of organization. However, Borrowers agree that they will return M-FRCI to good standing in its jurisdiction of
organization no later than April 12, 2004, and agree that the failure to return M-FRCI to good standing in its jurisdiction of organization as soon as practicable, but in any event
no later than April 12, 2004, will constitute an Event of Default under Section 11.1(b) of the Agreement. 

        3.     ACKNOWLEDGMENT OF THE BORROWERS.    The Borrowers acknowledge and agree that the Lenders executing this
Amendment have done so in their sole discretion and without any obligation to consent to any other or future amendments to the Agreement. The Borrowers further acknowledge and agree that any action
taken or not taken by the Lenders or the Administrative Agent prior to, on or after the date hereof shall not constitute a waiver or modification of any term, covenant or provision of any Loan
Document. 

        4.     REPRESENTATIONS AND WARRANTIES.    By its execution and delivery hereof, the Borrowers represent and warrant to
the Lenders that, as of the date hereof the representations and warranties contained in the Agreement and the other Loan Documents are true and correct in all material respects on and as of the date
hereof as if made on and as of such date, and no event has occurred and is continuing which constitutes a Default or an Event of Default. 

        5.     CONDITIONS OF EFFECTIVENESS.    This Amendment shall be effective as of the Effective Date upon execution by all
of the Lenders and the other parties hereto, so long as (i) all corporate actions of Borrowers taken in connection herewith and the transactions contemplated hereby shall be satisfactory in
form and substance to Administrative Agent and Lenders, (ii) Administrative Agent shall have received from Borrowers, for the ratable benefit of all Lenders (based upon the dollar amount set
forth beside each respective Lender's name under the heading "Commitment" on the signature pages of this Amendment), an amendment fee in the amount of $125,000, and (iii) Administrative Agent
shall have received such other documents, certificates, and instruments as Administrative Agent shall reasonably require prior to the Agent's receipt of this Amendment executed by the Majority Lenders
and the other parties hereto. 

        6.     REFERENCE TO AGREEMENT.    Upon the effectiveness of this Amendment, each reference in the Agreement to "this
Agreement," "hereunder," or words of like import shall mean and be a reference to the Agreement, as affected and amended by this Amendment. 

        7.     COUNTERPARTS; EXECUTION VIA FACSIMILE.    This Amendment may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Amendment may be validly executed and delivered by facsimile or other electronic
transmission. 

        8.     GOVERNING LAW: BINDING EFFECT.    This Amendment shall be governed by and construed in accordance with the laws
of the State of Texas and shall be binding upon the Borrower, the Administrative Agent, each Lender and their respective successors and assigns. 

        9.     HEADINGS.    Section headings in this Amendment are included herein for convenience of reference only and shall
not constitute a part of this Amendment for any other purpose. 

        10.   LOAN DOCUMENT.    This Amendment is a Loan Document and is subject to all provisions of the Agreement
applicable to Loan Documents, all of which are incorporated in this Amendment by reference the same as if set forth in this Amendment verbatim. 

        11.   ACKNOWLEDGEMENT OF LENDERS.    Each Lender acknowledges that as of the date of this Amendment, and giving
effect to this Amendment, it's respective Commitment is as set forth opposite its respective signature to this Amendment. 

3

 

        12.   FEES AND EXPENSES.    Borrowers agree to pay all reasonable out-of-pocket fees and
expenses of the Administrative Agent in connection with the Loan Documents, including this Amendment, including without limitation, appraisal fees, filing and recording fees, legal and other
professional fees and expenses, if any, incurred on or prior to the date of this Amendment by Administrative Agent, including, without limitation, the fees and expenses of Winstead Sechrest &
Minick P.C. 

        13.   NO ORAL AGREEMENTS.    THIS WRITTEN AGREEMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT
BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES. 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK] 

4

 

        IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as the date first above written. 

	 	 	AGENT:
	

 	
 	

BANK OF AMERICA, NATIONAL ASSOCIATION
	

 	
 	

By:	

/s/  ROBERT SCALZITTI      
 Name: Robert Scalzitti

Title: Vice President

5

 

	 	 	BORROWERS:
	

 	
 	

METALS USA, INC.
	

 	
 	

By:	

/s/  TERRY FREEMAN      
 Name: Terry L. Freeman

Title: Senior Vice President and Chief Financial Officer
	

 	
 	

METALS USA BUILDING PRODUCTS, L.P.

(f/k/a "ALLMET BUILDING PRODUCTS, L.P.")

        By: Allmet GP, Inc., its General Partner

ALLMET GP, INC.

ALLMET LP, INC.

INTERSTATE STEEL SUPPLY CO. OF MARYLAND, INC.

INTSEL GP, INC.

INTSEL LP, INC.

i-SOLUTIONS DIRECT, INC.

JEFFREYS REAL ESTATE CORPORATION

LEVINSON STEEL GP, INC.

LEVINSON STEEL LP, INC.

METALS RECEIVABLES CORPORATION

METALS USA CARBON FLAT ROLLED, INC.

METALS USA FINANCE CORP.

METALS USA FLAT ROLLED CENTRAL, INC.

METALS USA MANAGEMENT CO., L.P.

        By: MUSA GP, Inc., its General Partner

METALS USA PLATES AND SHAPES, NORTHEAST, L.P.

        By: Levinson Steel GP, Inc., its General Partner

METALS USA PLATES AND SHAPES SOUTHCENTRAL, INC.

METALS USA PLATES AND SHAPES SOUTHEAST, INC.

METALS USA PLATES AND SHAPES SOUTHWEST, LIMITED PARTNERSHIP

        By: Intsel GP, Inc., its General Partner

METALS USA REALTY COMPANY

METALS USA SPECIALTY METALS NORTHCENTRAL, INC.

MUSA GP, INC.

MUSA LP, INC.

QUEENSBORO, L.L.C.

By: Metals USA Plates and Shapes Southeast, Inc., its sole Member
	

 	
 	

By:	

/s/  TERRY FREEMAN      
 Name: Terry L. Freeman

Title: Vice President of each of the above-listed entities

6

QuickLinks

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT

RECITALS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]